These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25456009)

  • 1. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
    Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ
    Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
    Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
    Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas.
    Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
    Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
    Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
    BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
    Ortiz IMDP; Barros-Filho MC; Dos Reis MB; Beltrami CM; Marchi FA; Kuasne H; do Canto LM; de Mello JBH; Abildgaard C; Pinto CAL; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2018 Nov; 10(1):144. PubMed ID: 30454026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
    Chou CK; Liu RT; Kang HY
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
    Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
    Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.